The proteomics industry is poised for significant growth and advancements in the near future. Proteomics, the study of proteins and their functions within biological systems, plays a crucial role in understanding disease mechanisms, identifying therapeutic targets, and developing personalized medicine approaches. With advancements in technology and analytical techniques, the proteomics industry is expected to witness remarkable progress. One of the key areas of growth is the development of high-throughput proteomics platforms that enable the analysis of large numbers of proteins simultaneously. This allows for a comprehensive understanding of complex protein networks and their interactions, leading to insights into disease pathways and potential biomarkers. Additionally, advancements in mass spectrometry and bioinformatics tools are enhancing the accuracy and speed of protein identification and quantification. This enables researchers to delve deeper into proteomic data and extract meaningful information for drug discovery, precision medicine, and diagnostics. Moreover, the integration of proteomics with other omics technologies, such as genomics and metabolomics, holds immense potential for gaining a holistic understanding of biological systems and disease processes. Overall, the proteomics industry is expected to contribute significantly to advancements in medical research, diagnostics, and therapeutic development, ultimately leading to improved patient outcomes in the near future.
Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) – Global Forecasts to 2028″, size is projected to reach USD 72.9 billion by 2028 from 36.8 billion in 2023, at a CAGR of 14.6% during the forecast period. Factors such as increasing investments in the development of structure-based drug design, growing research in the field of omics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics are driving the growth of this market. However, challenges associated with data management are the major factors restraining the growth of this market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731
Browse in-depth TOC on “Proteomics Market”
707 – Tables
49 – Figures
604 – Pages
Driver: Technological Advancement in proteomics is likely to propel the market growth
The field of proteomics has been revolutionized by technological advancements that have greatly improved sensitivity and resolution, allowed for high-throughput and multiplexed analysis, facilitated data integration, enhanced sample preparation and fractionation techniques, enabled mass spectrometry-based imaging, and provided advanced data analysis and informatics tools. These advancements have played a pivotal role in driving the growth of the market by enabling a thorough and comprehensive understanding of the proteome. They have accelerated biomarker discovery, propelled advancements in personalized medicine, and facilitated drug discovery and development. These technological advancements have expanded the capabilities of proteomics research, enabling comprehensive and in-depth exploration of proteins in various biological contexts. They have led to breakthroughs in understanding protein functions, disease mechanisms, drug discovery, and personalized medicine, driving the growth and impact of proteomics as a field of study.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=731
Proteomics Market Dynamics:
- Increasing demand for personalized medicines for clinical practices
- Rising incidences of chronic diseases among geriatric population
- Increased investments in research and greater adoption of proteomics in drug discovery
- Technological advancements in proteomics
- High costs of proteomics instruments and technologies
- Lack of standardization in proteomics workflow among research groups
- High growth opportunities for proteomics research in emerging countries
- Growing prominence of nano proteomics in biological processes
- Low biomarker discovery to approval ratio in proteomics research
- Lack of data management/handling in proteomics research
Key Market Players:
Some of the prominent players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) and among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=731
- In February 2023, Waters Corporation acquired Wyatt Technology, which enhances the portfolio of Separation and Detection, which provides customers with an unmatched set of analytical solutions across a wide range of applications.
- In October 2022, Agilent Technologies Inc. and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.
- In November 2021, Thermo Fisher Scientific acquired Belgium-based Pharmafluidics, the developer of the μPAC range of micro-chip-based chromatography columns. The µpac portfolio of columns enhances liquid chromatography (lc) performance in biomarker, proteomics, and drug r&d applications, helping biotechnology and pharmaceutical companies uncover new insights and advance scientific discovery.
Table of Content:
1 INTRODUCTION (Page No. – 70)
- STUDY OBJECTIVES
- MARKET DEFINITION AND SCOPE
- CURRENCY CONSIDERED
- RESEARCH LIMITATIONS
- SUMMARY OF CHANGES
- RESEARCH METHODOLOGY (Page No. – 76)
- RESEARCH DATA
- MARKET SIZE ESTIMATION
- GROWTH RATE ASSUMPTIONS
- MARKET BREAKDOWN AND DATA TRIANGULATION
- STUDY ASSUMPTIONS
- EXECUTIVE SUMMARY (Page No. – 88)
- PREMIUM INSIGHTS (Page No. – 93)
- OVERVIEW OF PROTEOMICS MARKET
- NORTH AMERICA: MARKET SHARE, BY APPLICATION AND COUNTRY (2022)
- ELECTROPHORESIS MARKET SHARE, BY TYPE, 2023 VS. 2028 (USD MILLION)
- MARKET SHARE, BY END USER (2022)
- MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
- MARKET OVERVIEW (Page No. – 97)
5.2 MARKET DYNAMICS
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Visit Our Website: https://www.marketsandmarkets.com
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are moulded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit MarketsandMarkets™ or follow us on Twitter, LinkedIn and Facebook.